Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes.
Hope CM, Welch J, Mohandas A, Pederson S, Hill D, Gundsambuu B, Eastaff-Leung N, Grosse R, Bresatz S, Ang G, Papademetrios M, Zola H, Duhen T, Campbell D, Brown CY, Krumbiegel D, Sadlon T, Couper JJ, Barry SC.
Hope CM, et al.
Eur J Immunol. 2019 Aug;49(8):1235-1250. doi: 10.1002/eji.201948094. Epub 2019 Jun 5.
Eur J Immunol. 2019.
PMID: 31127857
Free article.